Chiropractors in Sheridan, AR Accepting Medicare

6 Chiropractors found. Showing 1 - 6

Sheridan Chiropractic Clinic, P.a. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 12 Opportunity Dr, Sheridan, AR 72150 Phone: 870-942-8014

Dr. Jolee Higginbotham, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 610 Little Creek Cut Off Rd, Sheridan, AR 72150 Phone: 870-600-9006

Dr. Richard F. Johnson, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 12 Opportunity Dr, Sheridan, AR 72150 Phone: 870-942-8014    Fax: 870-942-8014

P C Well, Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 610 Little Creek Cut Off Rd, Sheridan, AR 72150 Phone: 870-600-9006

Teh Chiro Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 109 W Pine St, Sheridan, AR 72150 Phone: 870-600-1213    Fax: 501-747-1044

Dr. Rocky Vannucci, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 401 N Rock St, Sheridan, AR 72150 Phone: 870-942-4646

News Archive

Skeletal age calculator aims to better identify individuals at risk of bone fractures

Researchers at the Garvan Institute of Medical Research have developed a computational model to calculate 'skeletal age', a personalized estimate of an individual's risk of bone fracture and premature death.

Survival of COVID-19 patients experiencing cardiac arrest is similar to pre-pandemic rates

It isn't a death sentence if a COVID-19 patient suffers a cardiac arrest while getting treatment for the virus in the hospital, according to new research that contradicts reports from early on in the pandemic.

UCLA researchers discover how chronic inflammation increases prostate cancer risk

UCLA researchers have discovered a previously unrecognized type of progenitor cell that, though rare in most regions of the human prostate, is found in uncommonly high numbers in inflamed areas of the gland.

Pharma Lynx licenses NewCardio's QTinno automated cardiac safety solution

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.

UV LED therapy can be used for treating focal epilepsy in humans

Researchers from the University of Minnesota Medical School discovered that light from an ultraviolet diode (UV LED) reduced "seizure-like" activity in a rat epilepsy model. During the study, UV light released gamma aminobutyric acid (GABA) from the "caged" compound carbonyl amino butanoic acid (BC204).

Read more Medical News

› Verified 5 days ago